Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111667 · ClinicalTrials.gov registry record · NA
A Hybrid Effectiveness-Implementation Trial of a School-Based Teen Marijuana Checkup
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 264
- Enrollment target
NCT03111667: Completed NA study, sponsored by University of Washington.
NCT03111667 is a NA study that has completed, run by University of Washington. The registered enrollment target is 264 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03111667, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 264 participants
- Enrollment target
Study Summary
A hybrid effectiveness-implementation trial that is designed to assess the effectiveness of an intervention (The Teen Marijuana Check-Up) when delivered in real world settings. In addition, the study will assess the frequency of coaching support needed by providers to maintain adherent skill levels.
Primary Outcome
self-reported, retrospective number of marijuana use days in the past 60.
Interventions
- OTHER Treatment as Usual
- BEHAVIORAL Teen Marijuana Check Up
- BEHAVIORAL Gold Standard Coaching
- BEHAVIORAL As Needed Coaching
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2016-05-15 |
| Est. Completion | 2023-02-28 |
| Phase | NA |
What the finished NCT03111667 record still lists
NCT03111667 is an interventional study that assigns participants to a tested intervention. The registered 264 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 4 interventions - of which Treatment as Usual is the first listed.
NCT03111667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03111667 about?
NCT03111667 is a clinical study titled "A Hybrid Effectiveness-Implementation Trial of a School-Based Teen Marijuana Checkup". A hybrid effectiveness-implementation trial that is designed to assess the effectiveness of an intervention (The Teen Marijuana Check-Up) when delivered in real world settings. In addition, the study will assess the frequency of coaching support needed by providers to maintain adherent skill levels.
What is the current status of trial NCT03111667?
This trial is currently completed. It is a NA study. The enrollment target is 264 participants. The study started on 2016-05-15. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT03111667?
The interventions under investigation include: Treatment as Usual (OTHER), Teen Marijuana Check Up (BEHAVIORAL), Gold Standard Coaching (BEHAVIORAL), As Needed Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT03111667?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03111667's enrollment target sits among peer trials
264 395th of 2000 higher than 1,605 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
- NCT04295863 · 264 participants · Phase 1
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
- NCT05220202 · 264 participants · NA
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression
- NCT05473013 · 264 participants · NA
Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI